Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 6 May 2009, doi:10.1136/bmj.b945
Cite this as: BMJ 2009;338:b945
A M Murdoch, medical student 1, L P Thia, specialist registrar in paediatric respiratory medicine2, A Gupta, specialist registrar in paediatric respiratory medicine2, C L Hogg, consultant in paediatric respiratory medicine2
1 University of Glasgow, Glasgow G12 8QQ, 2 Royal Brompton Hospital, London SW3 6NP
Correspondence to: L Thia lthia{at}doctors.org.uk
A boy born at 38 weeks gestation presented with neonatal respiratory distress requiring oxygen and was found to have dextrocardia. During the first few years of life he had persistent mucopurulent rhinitis, intermittent wet cough, and bilateral serous otitis media. He was treated with several courses of oral and intravenous antibiotics for respiratory tract infections. The chest radiograph (figure
) was taken when he was 5 years old.
|
Short answers
Long answers
1 Abnormalities
Figure 2
shows the abnormalities.
|
Motile cilia move fluid across an epithelium and are present in the airways, the eustachian tube, ventricles of the brain, and the male and female reproductive tracts. Dysfunction of motile cilia causes impaired mucociliary clearance and retention of inhaled particles in the lung, paranasal sinuses, and middle ear. In the developing embryo, ciliary activity controls the movement of fluid that determines laterality. In patients with primary ciliary dyskinesia, organs can be on either side.
Ciliary dysfunction is implicated in a range of diseases known collectively as the ciliopathies: polycystic kidney disease and chronic tubulointerstitial nephritis, retinitis pigmentosa, sensorineural deafness and vestibular impairment, anosmia, hydrocephalus, and biliary atresia.7 All ciliopathies arise from defective cilia, but the range of symptoms varies because of the structural diversity of cilia.8
3 Other presentations
The estimated incidence of primary ciliary dyskinesia is 1 in 15 000 to 30 000 births. Symptoms are commonly present from birth or early infancy, but many patients will receive the diagnosis after a period of chronic ill health with recurrent lower respiratory tract infections, persistent serous otitis media, and possible hearing loss. Patients may report a history of neonatal respiratory distress requiring several days of treatment with oxygen; some have needed prolonged mechanical ventilation.2 Clinical manifestations include chronic bronchitis, chronic sinusitis, chronic otitis media, and reduced fertility. Many patients experience hearing loss, and some may also describe a poor sense of smell due to high mucus production in the sinuses. About half of patients with primary ciliary dyskinesia have Kartageners triad of situs inversus totalis, bronchiectasis, and rhinosinusitis,6 and 6% may present with complex congenital heart diseases with situs ambiguus.3
4 Screening and diagnostic tests
Screening tests for primary ciliary dyskinesia have their limitations. The saccharin test is designed to assess mucociliary function but is unreliable in children (and is not used in paediatric patients in the United Kingdom). The most sensitive and specific screening test is measurement of nasal nitric oxide, which is very low in patients with primary ciliary dyskinesia. This test is available only in specialist centres, however, and may be difficult to use in young children.4
Failure to diagnose the condition leads to progressive and permanent lung destruction and to inappropriate ear, nose, and throat surgery. Primary ciliary dyskinesia should be suspected, along with other possible diagnoses such as cystic fibrosis and immunological defects, in children who have a persistent "wet" sounding or productive cough.1
A chest x ray may be normal or show dextrocardia (in about half of patients) and therefore raise clinical suspicion. Other common x ray findings are hyperinflation and bronchial wall thickening.9 High resolution computed tomography may identify severity and distribution of the disease but is not diagnostic. In primary ciliary dyskinesia the middle and lower lobes are more commonly affected, as opposed to the upper lobes or a more diffuse pattern in cystic fibrosis. 10 Echocardiography may show complex congenital heart diseases.
Diagnosis can be confirmed from ciliary biopsy. This provides measurements of ciliary beat frequency, high speed analysis of ciliary beat pattern, detailed electron microscopy of ciliary ultrastructure, and, in some specialist centres, cell culture from biopsies. Primary cell culture, where successful, will confirm or exclude the diagnosis with 100% certainty.
Management
No specific treatments will correct ciliary dysfunction, and management is aimed at preventing deterioration in lung function. Where possible, patients should be cared for in a specialist respiratory unit, with joint care from otorhinolaryngology and audiology specialists with experience in this condition.
Patients should have regular respiratory monitoring, including pulmonary function tests, regular culturing of sputum and cough swabs, and, where appropriate, high resolution computed tomography to assess the extent of bronchiectasis. They should have regular airway clearance through physiotherapy and are encouraged to exercise regularly. Respiratory tract infections need to be treated aggressively with appropriate antibiotics. We found no good evidence to support the use of prophylactic antibiotics, mucolytics, or bronchodilators.1
Although management of primary ciliary dyskinesia is similar to cystic fibrosis, the prognosis is not. Patients with primary ciliary dyskinesia can have a normal or near normal lifespan if they are diagnosed and treated early to prevent the progression of lung disease. We found no data on the lifespan of patients with primary ciliary dyskinesia. In general, the condition is associated with a better prognosis than is cystic fibrosis. The disease has a wide spectrum of severity; some patients with severe bronchiectasis need lung transplantation in early adulthood.
Cite this as: BMJ 2009;338:b945
Provenance and peer review: Commissioned; externally peer reviewed.
Read all Rapid Responses